(Q35122553)

6 August 2017

Clarithromycin in treatment of early Lyme disease: a pilot study (English)

1 reference

6 August 2017

0 references

1 reference

3

B J Luft

1 reference

6 August 2017

R J Dattwyler

1

1 reference

PubMed ID

8834900

6 August 2017

E Grunwaldt

series ordinal

2

1 reference

PubMed ID

8834900

6 August 2017

language of work or name

English

0 references

publication date

1 February 1996

1 reference

6 August 2017

2

1 reference

Antimicrobial Agents and Chemotherapy

inferred from page(s)

published in

1 reference

6 August 2017

40

1 reference

6 August 2017

468-469

1 reference

6 August 2017

2

1 reference

Efficacy of clarithromycin for treatment of experimental Lyme disease in vivo

6 August 2017

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=163136

In-vitro and in-vivo susceptibility of Borrelia burgdorferi to azithromycin.

28 July 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=163136

Amoxycillin plus probenecid versus doxycycline for treatment of erythema migrans borreliosis

28 July 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=163136

Antibiotic therapy in early erythema migrans disease and related disorders

28 July 2018

1 reference

12 December 2020

Treatment of erythema chronicum migrans of Lyme disease

1 reference

12 December 2020

Comparative antimicrobial activity of the new macrolides against Borrelia burgdorferi

1 reference

12 December 2020

1 reference

12 December 2020

Treatment of early lyme disease

1 reference

12 December 2020

1 reference

12 December 2020

Identifiers

PMCID

163136

1 reference

6 August 2017

1 reference

PubMed ID

8834900